A non-virally engineered NKG2D CAR-T cell showed dose-dependent cytotoxicity against colorectal cancer cells in vitro, along with elevated secretion of IL-2 and IFN-γ compared to untransduced T cells (57). The gene discussed is KLRK1; the disease is colorectal cancer.